Ying Wang

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 4

Top Topics

Nlrp Inflammasome

Top Venues

British journal of pharmacology

Annals of the New York Academy of Sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Mo-Yu Ding, Chengqing Ning, Shao-Ru Chen, Hao-Ran Yin, Jing Xu, Ying Wang
Discovery of natural product derivative triptolidiol as a direct NLRP3 inhibitor by reducing K63-specific ubiquitination. British journal of pharmacology (2024)
Chuan-Han Deng, Tian-Qi Li, Wei Zhang, Qi Zhao, Ying Wang
Targeting Inflammasome Activation in Viral Infection: A Therapeutic Solution? Viruses 15 (7) (2023)
Dan Li, Qianyu Liu, Wen Sun, Xiuping Chen, Ying Wang, Yuxiang Sun, Li-Gen Lin
1,3,6,7-Tetrahydroxy-8-prenylxanthone ameliorates inflammatory responses resulting from the paracrine interaction of adipocytes and macrophages. British journal of pharmacology 175 (10) (2018)
Bao-Jian Guo, Zhao-Xiang Bian, Hong-Cong Qiu, Yi-Tao Wang, Ying Wang
Biological and clinical implications of herbal medicine and natural products for the treatment of inflammatory bowel disease. Annals of the New York Academy of Sciences 1401 (1) (2017)